April 22, 2015
Please join Fitch, Even, Tabin & Flannery LLP for a complimentary webinar, “Practical and Ethical Issues in Compensating Fact Witnesses: Are the Benefits Worth the Headache?” presented by Eric L. Broxterman. The webinar will take place on Wednesday, April 22, 2015, at 9:00 am PDT / 10:00 am MDT / 11:00 am CDT / 12:00 noon EDT.
Not only expert witnesses request payment for their time preparing for trial and their testimony, as once was the trend. Now fact witnesses with special knowledge about the case sometimes expect to be compensated as well. Although rules regarding compensation of fact witnesses have loosened over the years, such payments are not unconstrained. ABA Model Rule 3.4 (b) and the Federal Anti-Gratuity Statute provide some guidance on this topic, but have been criticized for being too vague.
In this webinar, you will learn practical advice on how to structure payments to fact witnesses, how to disclose such payments to opposing counsel, and other procedures that will not only help deflect the unavoidable appearance of impropriety associated from such payments, but will also help prevent sanctions from the court.
During the webinar, we will discuss the following:
- An overview and interpretation of rules and statutes relating to compensation of fact witnesses
- Exemplary legal opinions dealing with such compensation
- Structuring and disclosing payments
- Sanctions and other ramifications if compensation is done incorrectly
Our speaker will be Fitch Even partner Eric L. Broxterman. Eric is a litigator with extensive trial experience in patent cases. A registered patent attorney, he also counsels clients on patent prosecution, infringement/invalidity opinions, and IP transactional issues.
IP Alert | Stock Ownership Leads to Vacatur of $2.75B District Court JudgmentAugust 8, 2022
On June 23, in Centripetal Networks v. Cisco Systems, the Federal Circuit vacated judgment of the district court because stock held by the judge's wife violated the recusal statute and was not harmless error. Read more
IP Alert | Rehearing Reverses Earlier Federal Circuit Decision Finding Silence Supported Negative Claim LimitationJuly 6, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation was not supported by silence in the patent's specification. Read more